SYS-CON MEDIA Authors: Kevin Benedict, Jason Bloomberg, Bob Gourley, Greg Schulz, Don Nelson

News Feed Item

Aesculap, Inc. Launches Lyoplant(R) Onlay Dura Substitute

A Biological, Collagen Based, Absorbable Dura Substitute Consisting of a Bi-Layer Membrane; Designed to Provide Superior Protection and Ease of Use

CENTER VALLEY, PA--(Marketwired - July 03, 2014) - Aesculap, Inc. is pleased to announce the availability of Lyoplant® Onlay, a biological, collagen based, absorbable dura substitution consisting of a bilayer membrane, designed to provide an elevated ease of use. The revolutionary product allows for a simple onlay application with the opportunity to incorporate suture fixation, if necessary.

Reliable

  • Helps protect against CSF leakage
  • Excellent resorption rates
  • Superior tensile strength,10x stronger than Suturable DuraGen*
  • Strong biocompatibility

Simple

  • Familiar use
  • Time-saving onlay application
  • Convenient handling
  • Superior suture pull-out, 10x stronger than Suturable DuraGen*

Versatile

  • Multi-use: Onlay or Suturable
  • 40% thinner than Suturable DuraGen*
  • Excellent elasticity and flexibility
  • Helps prevent cortical adhesion

Lyoplant Onlay is indicated as a dura substitute for the repair of the dura mater. To learn more about Lyoplant Onlay, visit aesculapusa.com/products/neurosurgery/dura-substitutesor contact your local Aesculap Sales Representative.

*Biomechanical data is on file at Aesculap, Inc. All testing results are based on averages. Tensile strength and suture retention testing were performed in a rehydrated state.

About Aesculap, Inc.

Aesculap, Inc., a B. Braun company, is part of a 175-year-old global organization focused on meeting the needs of an ever-changing healthcare community. Through close collaboration with its customers, Aesculap provides advanced technologies for general surgery, neurosurgery and closure technologies. Aesculap continues a proud heritage of leadership and responsiveness as we strive to deliver products and services that improve the quality of patients' lives. For more information, call 800-282-9000 or visit aesculapusa.com.

The following files are available for download:

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.